Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on SUPERGLASS HOLDINGS PLC. We currently have 8 research reports from 1 professional analysts.
|21Sep16 10:13||RNS||Holding(s) in Company|
|16Sep16 05:05||RNS||Holding(s) in Company|
|15Sep16 12:14||RNS||Holding(s) in Company|
|15Sep16 12:11||RNS||Holding(s) in Company|
|15Sep16 12:08||RNS||Holding(s) in Company|
|02Sep16 04:26||RNS||Holding(s) in Company|
|31Aug16 07:05||RNS||Intention to delist and Board changes|
Frequency of research reports
Research reports on
SUPERGLASS HOLDINGS PLC
SUPERGLASS HOLDINGS PLC
Interim results in line; Turnaround plan on track
29 Apr 16
As flagged in the March trading update, this morning’s interim results are in line with expectations. After reducing losses at the adj. LBITDA level in the first half (£1.4m YoY upswing to deliver a loss of £0.5m), the Group is on track to deliver positive EBITDA for the first full year since 2012, a significant improvement. After a planned shift in the customer and product mix, revenue growth of 2% supported this result. The Group has made solid progress in implementing its ongoing turnaround plan, with the delivery of a 9% YoY reduction in production costs per tonne and a 22% YoY reduction in distribution costs per tonne. We have tweaked our forecasts this morning, with current year EBITDA now expected to be £0.8m from £1.0m and FY’17 EBITDA expected to be £2.2m from £2.6m as further expected cost savings and production efficiencies broadly offset a reduction in our revenue forecast. The outlook for Superglass is positive, with further improvements in the product and customer mix, and further cost savings expected.
Trading in line at half year end
10 Mar 16
Superglass’ trading update this morning confirms that the Group is trading in line with expectations at the half year stage. An H116 EBITDA loss of £0.5m is a marked improvement on the prior year and similar to the H215 outturn (£0.4m), which is a seasonally slower period given the Christmas break. Cost saving initiatives and production efficiencies are having the desired effect and the business mix has, again, improved. The Group is on track to deliver positive EBITDA for the current financial year as a whole and continues to trade with adequate cash headroom (£2.4m gross cash at the February period end).
Trading in line, more pricing improvements to come
19 Nov 15
Superglass’ FY15 results are in line with expectations. H2’15 saw a significant improvement in EBITDA (£0.4m adjusted loss versus £1.9m adjusted loss in H1). This bodes well for FY16 and, encouragingly, guidance is maintained. The new year stands to benefit from new product introductions, ongoing cost initiatives and another price increase in February. Management’s focus is now very much on margin improvement and cash generation rather than volume, which should support the transition to profitability over the forecast period after the challenges of recent years.
Panmure Morning Note 30-11-2016
30 Nov 16
RPC, the international plastics products design and engineering group, has delivered yet another strong set of results (1H17 EBITDA +65%, EPS +45%). At the interim stage PBT was +66% (materially better than we had forecast). Topline growth has principally being driven by acquisitions (GCS + BPI), though organic remains a feature (and crucially remains at levels consistent with FY16). The two recent acquisitions have quickly been assimilated into the panEuropean platform and management has raised cost synergy guidance (again).
N+1 Singer - Morning Song 30-11-2016
30 Nov 16
Sanderson has delivered full year results in line with expectations and the 19 October trading update after a strong finish to the year compensated for a slower start. A healthy level of pre-contracted recurring revenue (50%), incremental sales to existing customers and new customer wins at higher average order values helped deliver solid revenue growth in both the Digital Retail (+9%) and Enterprise (+12%) divisions. A decent order book and good sales momentum suggest that the company is on track to deliver on unchanged profit expectations for the current year. We continue to view the valuation (FY17 EV/EBITDA 8.6x) as undemanding given an attractive combination of accelerating growth potential, strong cash generation and growing dividends.
Panmure Morning Note 02-12-16
02 Dec 16
Today James Halstead will be holding its 101st AGM. Trading during the first part of FY17 has been mixed, with some notable challenges. However, movements in FX (i.e. weak sterling) is boosting reported earnings, offsetting UK volume trends and pricing pressures. Whilst earnings are likely to be second half weighted, the picture is in-line with expectations and we are leaving our FY17 PBT estimates unchanged (£47.4m in FY17 vs £45.4m FY16).
02 Dec 16
On 30 September 2016, when the company announced its full year results, it reported that the UK business had seen a slow start to the year, with particular weakness in repair and renewal spending by the NHS as well as “reticence” in the education sector. However, with the UK only representing about a third of the business, this weakness was expected to be more than offset by the positive effect of a weakened sterling on its overseas business, given the benefits for competitiveness and margins.
06 Dec 16
600 Group* (SIXH): Interim results: order book showing signs of improvement (CORP) | Real Good Food* (RGD): Commodity volatility impacts numbers (CORP) | Minds + Machines* (MMX): .vip goes live in China (CORP | Imaginatik* (IMTK): Interims (CORP) | iomart* (IOM): Quality business as usual (CORP) | Fulcrum (FCRM): Upgrades continue (BUY)